
Ncardia Acquires STAR-CRISPR Technology for Advanced Gene Editing of iPSCs

Press release: Ncardia launches Cellistic, an iPSC cell therapy CDMO

Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of Process Development Technologies for the Manufacture of iPSC-derived Cardiomyocytes

iCone Consortium hits milestone in large-scale production of iPSC-derived cortical neurons